All Disease Treatment & Prevention articles – Page 2
-
NewsHow a CRISPR sickle cell therapy moved from lab to clinical trial
Researchers have described how they advanced an experimental CRISPR approach for sickle cell disease into a blood stem cell therapy that can be manufactured at the scale and quality required for a clinical trial.
-
NewsToothbrush produces electricity to battle plaque-making bacteria
A new toothbrush generates electricity through bristle movement to wage war on plaque-producing pathogens. The invention successfully reduced cavity- and periodontitis-causing bacteria better than regular mechanical brushing in the mouths of 115 volunteers over 3 months.
-
NewsNew CRISPR proteins expand editing access to heart disease genes
A researcher has used his AI-supported Sequence Display technology to expand the targeting abilities of CRISPR/Cas9, evolving several variants of a compact Cas9 that could efficiently target stretches of DNA previously inaccessible for editing. The evolved Cas9s were successfully used to edit two genes found in coronary heart disease.
-
NewsLow-level lead exposure linked to higher strep throat risk in children
Even relatively low levels of lead exposure may be linked to a higher risk of strep throat in children. In a study of more than 13,000 children, those with blood lead levels below current public health action thresholds still had substantially higher odds of a strep diagnosis.
-
NewsResearchers harness the microbiome to prevent deadly bloodstream infections
Researchers have pioneered a new approach to preventing dangerous bloodstream infections in patients receiving donor stem cell transplants for blood cancers. The first-of-its-kind therapy delivers 16 carefully selected beneficial bacteria designed to restore the microbiome and fight harmful pathogens.
-
NewsWho actually benefits from H. pylori treatment? A genetic score can tell before the first pill
In two Chinese randomized trials, a genetic score built from 11 variants identified people whose gastric cancer risk fell 56%–80% after Helicobacter pylori eradication — cutting the number needed to treat from 112 to 43.
-
NewsHalf of long COVID patients see meaningful symptom improvement within three years
A prospective cohort study found that about half of people living with long COVID a year after their initial COVID-19 infection experienced a meaningful symptom improvement within three years, whereas a quarter experienced a complete remission.
-
NewsAdvancing toward a functional cure for chronic hepatitis B: China’s evolving role
China has made progress in preventing HBV infections through infant vaccination and measures to prevent mother-to-child transmission. However, approximately 75 million people in the country still live with chronic HBV infection. A new review examine China’s contribution to developing treatments for chronic hepatitis B.
-
NewsGut bacteria emerge as potential targets after spinal cord injury
Spinal cord injury may reshape the gut microbiome in ways that influence inflammation, weight loss and muscle-related metabolism. Researchers have built a genome-level catalogue of gut microbes after injury and identified bacterial species that could become targets for future microbiome-based treatments.
-
NewsNew report calls for stronger One Health systems as climate risks grow
Climate change and shrinking global health budgets are increasing the pressure on systems designed to prevent diseases that spread between animals and people. A new report calls for stronger One Health surveillance, more investment in frontline veterinary and environmental services, and greater emphasis on preventing spillover before outbreaks begin.
-
News40-year mystery solved: Common gut virus infects bacteria, not human cells
Ever since one denizen of the gut microbiome, known as picobirnavirus, was first spotted decades ago, researchers thought it directly infected human tissue and played a role in gastrointestinal illness. But researchers have just rewritten that story: This widespread virus infects gut bacteria, not human cells.
-
NewsOne in four Americans have exaggerated or made up symptoms to try to get antibiotics
More than a quarter of Americans have exaggerated or made up symptoms to try to get antibiotics from their doctor, either for themselves or for their children, a new study has found.
-
NewsApilimod blocks hepatitis E virus entry by targeting PIKfyve
Hepatitis E virus (HEV) is a major cause of acute viral hepatitis, yet antiviral treatment remains largely limited to the off-label use of ribavirin. Seeking alternative treatments,scientists screened compounds that interfere with endocytic and endolysosomal pathways—the intracellular transport system used by HEV during cell entry.
-
NewsHPV-driven cell death pathways offer new directions for cervical cancer treatment
A new review proposes that PCD in cervical cancer should be understood not as a series of isolated pathways, but as an interconnected regulatory network that governs both tumor behavior and therapeutic sensitivity.
-
NewsMeasles outbreak shows how immunity gaps can unravel disease elimination
A year-long measles outbreak in Ontario was concentrated in closely connected, historically under-vaccinated communities and contributed to Canada losing its measles elimination status. Researchers warn that immunity gaps, cross-border social networks and declining trust in vaccination can quickly undermine decades of disease control.
-
NewsMarine compound shows promise against deadly brain-eating amoeba
A compound isolated from a marine bacterium may offer a faster way to attack Naegleria fowleri, the amoeba responsible for one of the deadliest known brain infections. In laboratory tests, rutamycin B reached full potency within four hours and was far more toxic to the parasite than to human cells.
-
NewsDrug-resistant bacteria in clinic air raise infection-control concerns
Air sampled inside a South African clinic contained multiple ESKAPE bacteria resistant to commonly used antibiotics, with some surviving even last-resort treatments. The findings raise concerns about airborne exposure in healthcare settings, particularly for patients with weakened immune systems.
-
NewsNew dosing data expands HIV treatment options for newborns
Newborns with HIV can now be treated with dolutegravir from the first days of life. An international clinical study identified a safe dosing regimen that produced drug levels comparable to those seen in older children and adults, helping support the FDA’s expanded approval.
-
NewsTargeting the gut-liver axis: New review explores microbial modulation to enhance immunotherapy in hepatocellular carcinoma
A review examines how gut microbiota and their metabolites reshape the hepatic immune microenvironment through the gut–liver axis, influence immune checkpoint inhibitor efficacy, and explore emerging combination strategies, including fecal microbiota transplantation, probiotics, engineered bacteria, and metabolite-based interventions.
-
News‘Raman barcodes’ can distinguish 20 SARS-CoV-2 variants
Viruses may carry a molecular ‘barcode’ hidden not just in their genetic sequence, but in the way their RNA folds and vibrates. Researchers have used Raman spectroscopy to distinguish 20 SARS-CoV-2 variants and subvariants, pointing towards a potentially faster way to screen emerging viral strains.